Biologics
Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo") announced the submission of a Phase...
November 11, 2026 | News
SINTBILO® (tafolecimab injection) monotherapy achieved significant reduction of LDL-C level, with > 60% mean LDL-C reduction after 12 weeks ...
November 10, 2026 | News
Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, ...
November 09, 2026 | News
33% investigator-assessed objective response rate and 90% disease control rate at 10 mg/kg every three weeks in patients with PD-(L)1-resistant/refrac...
November 09, 2026 | News
SG-INSIGHT study will extend whole-genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine could be i...
November 06, 2026 | News
Akeso, Inc. announced that ivonescimab in combination with chemotherapy for the first-line treatment of locally advanced or metastatic biliary tract cancer...
November 06, 2026 | News
Thera4Care is an initiative aimed at establishing an integrated theranostics ecosystem to broaden patient access in Europe Telix's fibroblast activation...
November 06, 2026 | News
Extended collaboration will accelerate research and development in advanced connectivity and emerging 5G Advanced & future 6G tec...
November 05, 2026 | News
The acquisition of our newly licensed Hangzhou facility establishes robust local sourcing capabilities to accelerate and support clinical trials across Chi...
November 05, 2026 | News
Minghui Pharmaceutical ("Minghui") and ASKA Pharmaceutical Co., Ltd. ("ASKA") announced that they have entered into an exclusive license agreement fo...
November 05, 2026 | News
Seventeen of them have already been licensed outside their home market, and the companies that will sell most of them in the US and Europe are Merck, Astra...
November 05, 2026 | Analysis
Brise Pharmaceuticals Co., Ltd. provided an update on its exclusive license agreement with AbbVie (NYSE: ABBV), which the companies entered in 2024. Under ...
November 04, 2026 | News
Neurophet, an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced a partnership with RapidAI, a global lea...
November 04, 2026 | News
Farrer Park Hospital (FPH) announced the introduction of the Edge® Multi-Port Endoscopic Surgical Robot (MP1000) in Singapore. As FPH celebrates its 10...
November 04, 2026 | News
Most Read
Bio Jobs
News